USD 7.48 billion
Heparin Market Size, Share, Growth Analysis, By Type(Low Molecular Weight Heparin, Ultra-low Molecular Weight Heparin, Unfractionated Heparin), By Route of Administration(Intravenous, Subcutaneous), By Source(Porcine, Bovine, Others), By Application(Venous Thromboembolism, Atrial Fibrillation, Renal Impairment, Coronary Artery Disease), By End-use(Outpatient, Inpatient), By Region - Industry Forecast 2024-2031
Report ID:
SQMIG35H2166 |
Region:
Global |
Published Date: September, 2024
Pages:
219
|Tables:
59
|Figures:
76
Heparin Market Insights
Global Heparin Market size was valued at USD 7.32 billion in 2022 and is poised to grow from USD 7.51 billion in 2023 to USD 9.22 billion by 2031, growing at a CAGR of 2.6% during the forecast period (2024-2031).
The global heparin market is a vital segment belonging to the healthcare and pharmaceutical industries, essentially focused on anticoagulant medications obtained from animal tissues. The market is considerably driven by the rising cases of cardiovascular diseases, the growing aging and geriatric population, and the rising number of surgical procedures. The growth in lifestyle-associated diseases is resulting in an increased need for anticoagulants. Also, the ever-growing aging population is notably raising the need and demand for heparin products. The market growth is also impacted by the growing number of hospitalization rates and surgeries that drive the demand for anticoagulation therapies. In addition, ongoing research and development, emphasizing the development of modernized heparin delivery systems and formulations is impacting the market growth.
Nonetheless, the global heparin market is negatively impacted by regulatory scrutiny, market competition, and risk of complications. Stringent regulatory needs and quality control protocols may offer challenges to the producers, negatively affecting the market growth. The introduction of alternative anticoagulants and generics may affect the heparin market share since providers may not prefer these novel therapies owing to their low monitoring needs. Heparin may also result in severe side-effects, comprising (HIT) heparin-induced thrombocytopenia and bleeding complications that may prevent healthcare providers from using it. Despite these challenges, the market is projected to flourish on the back of opportunities like the emergence of biosimilars, innovations in drug delivery systems, and expansion in progressing markets.
Market Snapshot - 2024-2031
Global Market Size
Largest Segment
Subcutaneous
Fastest Growth
Subcutaneous
Growth Rate
2.7% CAGR
Global Heparin Market ($ Bn)
Country Share for North America Region (%)
To get more reports on the above market click here to Buy The Report
Heparin Market Segmental Analysis
Global Heparin Market is segmented by Type, Route of Administration, Application, end user and region. Based on Type, the market is segmented into Low Molecular Weight Heparin, Ultra-low Molecular Weight Heparin, Unfractionated Heparin. Based on Route of Administration, the market is segmented into Intravenous, Subcutaneous. Based on Source, the market is segmented into Porcine, Bovine, Others. Based on Application, the market is segmented into Venous Thromboembolism, Atrial Fibrillation, Renal Impairment, Coronary Artery Disease, Others. Based on end user, the market is segmented into Outpatient, Inpatient. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.
Global Heparin Market Analysis by Type
Based on type, the heparin market is categorized into low molecular weight heparin, ultra-low molecular weight heparin, unfractionated heparin. The low molecular weight heparin segment held a notable share of the market in the previous years and is expected to lead over the forecast period as well owing to improved safety profile, better dosing convenience, and efficiency. Low molecular weight heparin holds comparatively less risk of heparin-induced bleeding complications and thrombocytopenia than the traditional unfractionated heparin. They can be administered well with fixed dosing, removing the need for continuous monitoring. It also provides efficient anticoagulation for different indications like PE and DVT, thus increasing its preference in clinics.
On the other hand, the ultra-low molecular weight heparin segment is projected to grow considerably over the forecast period owing to precise dosing, enhanced pharmacokinetics, and increasing demand for specialized treatments. Ultra-low molecular weight heparin offers an accurate dosage with minimum adverse effects, increasing its effectiveness for certain patient populations. It holds a more precise projected response and durable half-life, decreasing the need for repeated dosage. Its effectiveness in treating complicated conditions like certain surgical cases and cancers also fuels its adoption. Moreover, ultra-low molecular weight heparin can be administered through subcutaneous injection, improving patient compliance like the low molecular weight heparin.
Global Heparin Market Analysis by Application
Based on application, the market is segmented into venous thromboembolism, atrial fibrillation, renal impairment, coronary artery disease, and others. The coronary artery disease segment held a notable market share in the previous years and is expected to continue dominance over the forecast period as well owing to increased incidences of coronary artery disease, resulting in higher demand for anticoagulants for the prevention and treatment. Moreover, heparin is vital for effective management of acute coronary syndromes, comprising myocardial infarction, offering speedy anticoagulation during crucial mediations. Maximum patients with CAD undergo surgeries like bypass and angioplasty, wherein heparin plays a crucial role in avoiding thrombosis.
On the other hand, the atrial fibrillation segment is likely to hold a remarkable market share in the coming years owing to the increased prevalence of atrial fibrillation, better prevention of stroke, and peri-operative management. Atrial fibrillation is one of the commonly seen cardiac arrhythmia conditions, capturing a major patient population that demands anticoagulation. Heparin is vital in treating and managing atrial fibrillation patients who are at a higher risk of stroke, offering efficient anticoagulation to minimize thromboembolic happenings. In several atrial fibrillation patients that need anticoagulation like surgery or catheter ablation, heparin is widely utilized, thus considerably impacting the growth of the segment.
Global Heparin Market Size By Type
To get detailed analysis on other segments, Request For Free Sample Report
Heparin Market Regional Insights
Geographically, North America dominated the market in the previous years and is expected to lead over the forecast period owing to increasing incidences of diabetes and cardiovascular diseases, thus fueling the need for anticoagulants. North America also holds a well-established healthcare infrastructure with easy and improved access to superior technologies and treatments, encouraging the utilization of heparin. Furthermore, the region is a leading center for key pharmaceutical firms and several research institutes, resulting in continuous modernizations and novel heparin formulations. The key players profiled in the region include Pfizer Inc., Baxter International Inc., B. Braun Medical, Inc., Teva Pharmaceutical Industries Ltd., and more.
Asia-Pacific is the fastest-growing region in the global heparin market due to the ever-growing population, increasing healthcare expenditure, and widening medical infrastructure. Asia-Pacific holds a speedy and large aging population that raises the risk for chronic illnesses, comprising several cardiovascular conditions needing anticoagulation. Also, progressing economic growth has increased spending in healthcare, thus enhancing access to superior medical technologies and treatments like heparin. Besides, expanding medical infrastructure due to heavy investment is also driving the market in the region. Investments in healthcare services and infrastructure improve the distribution and availability of heparin products. These factors are driving the market growth in Asia-Pacific.
Global Heparin Market Size By Geography
- Largest
- Fastest
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Heparin Market Dynamics
Global Heparin Market Drivers
Growing Cases of Thromboembolic Disorders
- Cardiovascular diseases are the leading reasons for death and morbidity on the global scale. Conditions like heart attack, atrial fibrillation, and stroke considerably increase the risk of thromboembolic illnesses. This increases the need and demand for heparin-like anticoagulants. Also, the rising cases of PE and DVT are impacting the demand for heparin since it is regarded as the standard treatment for such disorders.
Rising Number of Surgical Procedures
- The number of surgical procedures conducted on the global scale is increasing owing to improvements in healthcare technologies, heavy focus on surgical intervention for chronic illnesses, and the rise in elective surgeries. Heparin is generally used to avert formation of clot during and after procedures, increasing its significance in peri-operative care. With the rise of surgical volume, the demand for heparin also increases considerably.
Restraints
Risk of Complication to Restrain Market
- Heparin therapy has severe side effects like bleeding, which may create hesitation among patients and refrain healthcare providers from using it. Conditions like HIT may also result in severe results that could notably impact confidence and safety in treatment. Also, unfractionated heparin needs close observation of (aPTT) activated partial for preventing complications and confirming efficiency of therapy. This may need intricate treatment routine, especially in outpatient departments.
Patient Acceptance and Compliance
- Most heparin products need administration through injection. This may be uncomfortable and inconvenient for patients and may result in low compliance, thus affecting market growth. Oral alternates are increasingly preferred due to high patient convenience. Healthcare providers need to educate their patients for potential adverse-effects and proper administration of heparin, which may result in inconsistent patient adherence.
Request Free Customization of this report to help us to meet your business objectives.
Heparin Market Competitive Landscape
The competitive landscape of the global heparin market is progressing with the combination of emerging players, established players, and startups, each aiming for a notable market share in the dynamic environment. Key players like Pfizer, Sanofi, B Braun Melsungen AG, Teva Pharmaceutical Industries, and LEO Pharma are emphasizing the development and marketing of heparin in niche therapeutic domains. Other are focusing on innovations in delivery and quality of heparin. Most companies are heavily investing in research and development to produce fresh delivery methods and novel formulations like advanced delivery systems and oral heparin. Overall, the market is evolving and is competitive with players focusing on strategic partnerships, and regulatory compliance.
Top Player’s Company Profiles in Global Heparin Market
- Pfizer Inc. (US)
- LEO Pharma A/S (Denmark)
- Dr. Reddy’s Laboratories Ltd. (India)
- Sanofi (France)
- Aspen Holdings (South Africa)
- Fresenius SE & Co. KGaA (Germany)
- B. Braun Medical, Inc. (US)
- Sandoz (Novartis AG) (Switzerland)
- Teva Pharmaceutical Industries Ltd. (Israel)
- Hikma Pharmaceuticals PLC (UK)
- Amphastar Pharmaceuticals, Inc. (US)
- Baxter International Inc. (US)
- Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (China)
- Bioiberica S.A.U. (Spain)
- CSL Limited (Australia)
- Laboratorios ROVI S.A. (Spain)
- Opocrin S.p.A. (Italy)
- Shandong Dongcheng Biochemicals Co., Ltd. (China)
- Techdow Pharmaceutical Co., Ltd. (China)
- Syntex S.A. (Argentina)
- Jiangxi Haike Biotechnology Co., Ltd. (China)
- Chemi S.p.A. (Italy)
- Changzhou Qianhong Bio-pharma Co., Ltd. (China)
- Hebei Changshan Biochemical Pharmaceutical Co., Ltd. (China)
- Hebei Yipin Pharmaceutical Co., Ltd. (China)
- King-friend Biochemical Pharmaceutical Co., Ltd. (China)
- Yantai Dongcheng Biochemicals Co., Ltd. (China)
- Nanjing Jianyou Biochemical Pharmaceutical Co., Ltd. (China)
Global Heparin Market Recent Developments
- In November 2023, Leo Pharma, Denmark, announced a cooperation contract with Vianex, a Greek Pharmaceutical for the development by latter of low molecular weight heparin and standard unfractionated heparin. The contract comprises the transmission of injectable preparations from Leo’s factory to the services of Vianex.
- In February 2024, B. Braun Medical, Inc. introduced its novel Heparin Sodium 2,000 units in Sodium Chloride 0.9% injection, (2 units/mL) 1000mL, 5th offering in its product line of Heparin premixed bags.
- In September 2024, Teva Pharmaceuticals announced novel positive safety, efficacy, and tolerability outcomes for Phase 3 (SOLARIS) Subcutaneous Olanzapine Extended-Release Injection Study experiment assessing TEV-‘749 in individuals suffering with schizophrenia.
Heparin Key Market Trends
- Heavy Focus on Biosimilars: The development of biosimilars has gained huge popularity in the market in recent years. As patents for original heparin products perish away, the improved biosimilars provide cost-efficient substitutes that help maintain similar safety and efficacy profiles. This key trend is mainly witnessed and seen on major regions like Europe and North America, where in medical providers aim to decrease cost of drugs without compromising patient care.
- Growing Awareness for Thromboembolic Disorders: Currently, the awareness for thromboembolic disorders is increasing on the global scale, especially among patients and healthcare professionals. Also, the initiatives for screening and creating awareness and education for risky populations like cancer, history of cardiovascular diseases, or obesity are increasing the need for heparin treatments. This trend is also backed by the growing public health campaigns, emphasizing on the significance of preventing PE (Pulmonary Embolism) and DVT (Deep Vein Thrombosis).
Heparin Market SkyQuest Analysis
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
As per SkyQuest analysis, the heparin market is considerably progressing due to increasing cases of chronic diseases and conditions, rising number of surgical procedures, and improvements in healthcare infrastructure. The market is also notably impacted by the favorable guidelines and regulations promoting heparin’s use. However, the market is hampered by the growing risk of side-effects, increased need for monitoring, issues with supply chain and variations in availability of raw materials. North America is anticipated to lead the market due to better awareness for anticoagulation treatments, the presence of improved healthcare infrastructure, and robust research and development. Nonetheless, a few opportunities for the growth of the heparin market include increasing innovations in formulation technologies, rising number of surgical procedures, emphasis on personalized medicine, and education and growing awareness.
| Report Metric | Details |
|---|---|
| Market size value in 2022 | USD 7.32 billion |
| Market size value in 2031 | USD 9.22 billion |
| Growth Rate | 2.6% |
| Base year | 2023 |
| Forecast period | 2024-2031 |
| Forecast Unit (Value) | USD Billion |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Table Of Content
Executive Summary
Market overview
- Exhibit: Executive Summary – Chart on Market Overview
- Exhibit: Executive Summary – Data Table on Market Overview
- Exhibit: Executive Summary – Chart on Heparin Market Characteristics
- Exhibit: Executive Summary – Chart on Market by Geography
- Exhibit: Executive Summary – Chart on Market Segmentation
- Exhibit: Executive Summary – Chart on Incremental Growth
- Exhibit: Executive Summary – Data Table on Incremental Growth
- Exhibit: Executive Summary – Chart on Vendor Market Positioning
Parent Market Analysis
Market overview
Market size
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- SWOT Analysis
KEY MARKET INSIGHTS
- Technology Analysis
- (Exhibit: Data Table: Name of technology and details)
- Pricing Analysis
- (Exhibit: Data Table: Name of technology and pricing details)
- Supply Chain Analysis
- (Exhibit: Detailed Supply Chain Presentation)
- Value Chain Analysis
- (Exhibit: Detailed Value Chain Presentation)
- Ecosystem Of the Market
- Exhibit: Parent Market Ecosystem Market Analysis
- Exhibit: Market Characteristics of Parent Market
- IP Analysis
- (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
- Trade Analysis
- (Exhibit: Data Table: Import and Export data details)
- Startup Analysis
- (Exhibit: Data Table: Emerging startups details)
- Raw Material Analysis
- (Exhibit: Data Table: Mapping of key raw materials)
- Innovation Matrix
- (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
- Pipeline product Analysis
- (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
- Macroeconomic Indicators
COVID IMPACT
- Introduction
- Impact On Economy—scenario Assessment
- Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
- Revised Market Size
- Exhibit: Data Table on Heparin Market size and forecast 2021-2027 ($ million)
- Impact Of COVID On Key Segments
- Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
- COVID Strategies By Company
- Exhibit: Analysis on key strategies adopted by companies
MARKET DYNAMICS & OUTLOOK
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- Regulatory Landscape
- Exhibit: Data Table on regulation from different region
- SWOT Analysis
- Porters Analysis
- Competitive rivalry
- Exhibit: Competitive rivalry Impact of key factors, 2021
- Threat of substitute products
- Exhibit: Threat of Substitute Products Impact of key factors, 2021
- Bargaining power of buyers
- Exhibit: buyers bargaining power Impact of key factors, 2021
- Threat of new entrants
- Exhibit: Threat of new entrants Impact of key factors, 2021
- Bargaining power of suppliers
- Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
- Competitive rivalry
- Skyquest special insights on future disruptions
- Political Impact
- Economic impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Market Size by Region
- Chart on Market share by geography 2021-2027 (%)
- Data Table on Market share by geography 2021-2027(%)
- North America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- USA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Canada
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Europe
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Germany
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Spain
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- France
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- UK
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Europe
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Asia Pacific
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- China
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- India
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Japan
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Korea
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Asia Pacific
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Latin America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Brazil
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of South America
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Middle East & Africa (MEA)
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- GCC Countries
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Africa
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of MEA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
KEY COMPANY PROFILES
- Competitive Landscape
- Total number of companies covered
- Exhibit: companies covered in the report, 2021
- Top companies market positioning
- Exhibit: company positioning matrix, 2021
- Top companies market Share
- Exhibit: Pie chart analysis on company market share, 2021(%)
- Total number of companies covered
Methodology
For the Heparin Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Heparin Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Heparin Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Heparin Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
USA (+1) 351-333-4748
